JP2000501697A5 - - Google Patents

Download PDF

Info

Publication number
JP2000501697A5
JP2000501697A5 JP1997507005A JP50700597A JP2000501697A5 JP 2000501697 A5 JP2000501697 A5 JP 2000501697A5 JP 1997507005 A JP1997507005 A JP 1997507005A JP 50700597 A JP50700597 A JP 50700597A JP 2000501697 A5 JP2000501697 A5 JP 2000501697A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997507005A
Other languages
English (en)
Other versions
JP4125369B2 (ja
JP2000501697A (ja
Filing date
Publication date
Priority claimed from AUPN4492A external-priority patent/AUPN449295A0/en
Application filed filed Critical
Publication of JP2000501697A publication Critical patent/JP2000501697A/ja
Publication of JP2000501697A5 publication Critical patent/JP2000501697A5/ja
Application granted granted Critical
Publication of JP4125369B2 publication Critical patent/JP4125369B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2000501697
Figure 2000501697
Figure 2000501697
Figure 2000501697
Figure 2000501697
Figure 2000501697
Figure 2000501697
Figure 2000501697
JP50700597A 1995-07-28 1996-07-26 放射線防護剤 Expired - Lifetime JP4125369B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN4492A AUPN449295A0 (en) 1995-07-28 1995-07-28 Radioprotectors
AU4492 1995-07-28
PCT/AU1996/000467 WO1997004776A1 (en) 1995-07-28 1996-07-26 Radioprotectors

Publications (3)

Publication Number Publication Date
JP2000501697A JP2000501697A (ja) 2000-02-15
JP2000501697A5 true JP2000501697A5 (ja) 2004-08-26
JP4125369B2 JP4125369B2 (ja) 2008-07-30

Family

ID=3788827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50700597A Expired - Lifetime JP4125369B2 (ja) 1995-07-28 1996-07-26 放射線防護剤

Country Status (9)

Country Link
US (2) US6194414B1 (ja)
EP (2) EP0857067A4 (ja)
JP (1) JP4125369B2 (ja)
AU (2) AUPN449295A0 (ja)
CA (1) CA2228044C (ja)
DK (1) DK2044938T3 (ja)
ES (1) ES2537054T3 (ja)
PT (1) PT2044938E (ja)
WO (1) WO1997004776A1 (ja)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0777656B1 (en) * 1994-08-26 2004-04-14 Auckland Division Cancer Society Of New Zealand (Incorporated) Novel dna-targeted alkylating agents
US6696473B2 (en) * 2001-12-21 2004-02-24 X-Ceptor Therapeutics, Inc. Heterocyclic modulators of nuclear receptors
WO2004082605A2 (en) * 2003-03-14 2004-09-30 Merck & Co. Inc. Bicyclic anilide spirohydantoin cgrp receptor antagonists
AU2004222378B2 (en) * 2003-03-14 2008-08-14 Merck Sharp & Dohme Corp. Carboxamide spirohydantoin CGRP receptor antagonists
US8097238B2 (en) 2004-02-27 2012-01-17 Peter Maccallum Cancer Institute Cell targeting conjugates
WO2006009734A1 (en) * 2004-06-17 2006-01-26 Wyeth Gonadotropin releasing hormone receptor antagonists
WO2006009736A1 (en) * 2004-06-17 2006-01-26 Wyeth Processes for preparing gonadotropin releasing hormone receptor antagonists
JP5149620B2 (ja) 2004-07-23 2013-02-20 エンドサイト,インコーポレイテッド 2価リンカーおよびその結合体
JP2008512456A (ja) * 2004-09-09 2008-04-24 メルク エンド カムパニー インコーポレーテッド 三環式アニリドスピロラクタムcgrp受容体拮抗薬
CN101048383A (zh) * 2004-11-23 2007-10-03 惠氏公司 促性腺激素释放激素受体拮抗剂
US7538113B2 (en) * 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) * 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) * 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US20060189619A1 (en) * 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
DE102005019549A1 (de) * 2005-04-25 2006-12-14 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) * 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
EP1909910A1 (en) 2005-08-04 2008-04-16 Sirtris Pharmaceuticals, Inc. Benzimidazole derivatives as sirtuin modulators
WO2008073451A2 (en) * 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
US8796277B2 (en) 2006-12-21 2014-08-05 Peter Maccallum Cancer Institute Radioprotector compounds and related methods
NZ580132A (en) 2007-03-14 2012-11-30 Endocyte Inc Binding ligand linked drug delivery conjugates of tubulysins to vitamins
CL2008001822A1 (es) 2007-06-20 2009-03-13 Sirtris Pharmaceuticals Inc Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CN104383553A (zh) 2007-06-25 2015-03-04 恩多塞特公司 含有亲水性间隔区接头的共轭物
EA021424B1 (ru) 2008-12-19 2015-06-30 Сертрис Фармасьютикалз, Инк. Тиазолопиридиновые соединения, регулирующие сиртуин
NZ602773A (en) 2010-04-06 2015-05-29 Peter Maccallum Cancer Inst Radioprotector compounds and methods
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
JP2015536323A (ja) 2012-10-16 2015-12-21 エンドサイト・インコーポレイテッドEndocyte, Inc. 非天然アミノ酸を含む薬物送達結合体および使用方法
WO2016148674A1 (en) * 2015-03-13 2016-09-22 Endocyte, Inc. Conjugates for treating diseases
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
RU205631U1 (ru) * 2021-01-11 2021-07-23 Общество с ограниченной ответственностью "Газпром добыча Уренгой" Устройство для поверки и калибровки средств измерений малого давления

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670684A1 (de) * 1966-04-01 1970-12-03 Hoechst Ag Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
US5641764A (en) * 1989-03-31 1997-06-24 Peter Maccallum Institute Halogenated DNA ligand radiosensitizers for cancer therapy
WO1990012321A1 (en) * 1989-03-31 1990-10-18 The Cancer Institute Board Halogenated dna ligand radiosensitisers for cancer therapy

Similar Documents

Publication Publication Date Title
JP2000515114A5 (ja)
JP2000500228A5 (ja)
JP2000500033A5 (ja)
JP2000500440A5 (ja)
JP2000500445A5 (ja)
JP2000500327A5 (ja)
JP2000516195A5 (ja)
JP2000500155A5 (ja)
JP2000500406A5 (ja)
JP2000500361A5 (ja)
JP2000500115A5 (ja)
JPH11512513A5 (ja)
JP2000500258A5 (ja)
JP2000500342A5 (ja)
JP2000500192A5 (ja)
JP2000500112A5 (ja)
JP2000500051A5 (ja)
JP2000500166A5 (ja)
JP2000500397A5 (ja)
JP2000500019A5 (ja)
JP2000514177A5 (ja)
JP2000500125A5 (ja)
JP2001517922A5 (ja)
JP2000500044A5 (ja)
JP2000500257A5 (ja)